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Introduction 
• 51 year old ,male presents to the Mackay Base 
Hospital with an episode of small bowel 
perforation in Feb 2013 on the background of 3 
episodes of hematemesis.   
 
• Multiple admissions over subsequent months for 
abdominal pain. Ct in August 2013 showed 
pneumobilia. 
 
 
• Given these findings the patient went on to 
undergo an upper gastrointestinal endoscopy  
which showed extensive ulceration of the 
esophagus and duodenum ( 3 ulcers; non-
bleeding with clean base). Duodenal papilla was 
distorted by the degree of inflammation. 
 
• Histology from gastroscopy ( Aug 2013):  
▫ Gastro-esophageal junction: Extensive ulceration 
of esophageal mucosa; -ve malignancy; +ve for 
Candida 
▫ D2: Erosive acute duodenitis with evidence of 
regenerative atypia 
 
 
 Gastroscopy images carried 
out on the patient in August 
2013 
• The patient then presented to Mackay again with 
a small bowel perforation on the 6th of Jan 2014 
and had to undergo resection of the proximal 
jejunum. 
• There was no evidence of Crohn’s on histology. 
Case referred on to Gastroenterology service at 
referral centre whilst pt on steroids and AZT. 
• Represented to MBH March 2014 with 
contained perforation that was drained 
percutaneously. 
Histology from the laparotomy in Jan 
2014( 2nd laparotomy): 
• Proximal Jejunal biopsy: 
▫ Heterotopic gastric mucosa 
▫ Ulceration and possible perforation 
 
• Terminal ileum: 
▫ Serosal inflammation and fibrosis related to 
previous perforation 
▫ Benign gastrointestinal stromal tumour (GIST) 
• Subsequent discussion of pt’s case at radiology 
meeting demonstrated a subtle  lesion at the tail 
of the pancreas. 
• Pt was happy to inform ( in retrospect) that his 
family had a high incidence MEN 1.  
• Subsequent testing demonstrated : 
▫ Gastrin    6280 ng/L ( on ppi) 
▫ Prolactin 11,400 mU/L 
▫ Parathyroid level 7.6  
▫ Normal TSH , T4, insulin and fasting glucose 
Ga-Dotatate scan identifying lesion in body and tail of pancreas 
with 3cm porto-caval node also highlighted on axial scan 
Sestamibi nuclear medicine scan identifying functioning parathyroid adenoma in Right lower pole 
MRI brain T1 sequence identifying showing microadenoma in the posterior 
aspect of Left anterior pituitary 
• Features on MEN 1 on this patient: 
▫ Prolactinoma 
 MRI: small microadenoma in post. Left pituitary 
measuring 5x4x4mm suggestive of micro 
prolactinoma 
 On Cabergoline treatment 
▫ Hyperparathyroidism 
 Pt underwent subtotal parathyroidectomy + 
thymectomy and auto-tranplantation into the 
forearm (14/5) 
 Histology : asymmetrical hyperplasia of parathyroid 
tissue  
▫ Gastrinoma 
 3cm porto-caval node is visible; involvement of body 
and tail of pancreas 
 Endoscopic US-guided FNA : gastrin secreting 
neuroendocrine tumour 
Approach to complex MEN 1 patients 
Management of parathyroid tumours 
• Surgery is prefered form of treatment (sub-total 
parathyroidectomy+thymectomy)(1) 
• If surgery contraindicated or 
hyperparathyroidism reoccurs, options: 
 Octreotide and Cinacalcet 
 Ethanol abalation 
Management of Zollinger Ellison 
Syndrome(ZES) 
 
• Medical management first line 
• Limits symptoms and complications  with high 
dose ppi ( 60mg od omeprazole, 120mg od 
esomeprazole, 120mg od pantoprazole)(2) 
• Surgery: Indications  
▫ Extra-pancreatic gastrinoma 
▫ Aggressive growth patterns 
▫ Exploratory laparotomy to identify lesions larger than 2cm 
Management of pituitary tumours 
• Prolactinoma – Dopamine agonists form the 
first line of treatment 
• Surgery(transsphenoidal  hypophysectomy) is 
first line treatment for other pituitary tumours 
and second line treatement for dopamine 
agonist resistant prolactinoma 
• Radiation therapy appropriate after noncurative 
pituitary surgery (3) 
 
Peculiar features about this case 
• Pt is part of a familial type MEN ( 3 identified 
first degree family members) whose 
chromosomal mutation has not yet been 
characterised. 
▫ Tested normal for cytogenetic testing in 2002 
• Patient presented with proximal bowel 
perforations ; an uncommon initial presenting 
feature. (4) 
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